Scarica l'app Stockscreener
2.05
12.29%
-0.31
Precedente Chiudi:
$2.36
Aprire:
$2.15
Volume 24 ore:
240.90K
Relative Volume:
0.06
Capitalizzazione di mercato:
$114.11M
Reddito:
$76.19M
Utile/perdita netta:
$-1.61M
Rapporto P/E:
205.00
EPS:
0.01
Flusso di cassa netto:
$28.98M
1 W Prestazione:
-8.41%
1M Prestazione:
-26.33%
6M Prestazione:
+153.46%
1 anno Prestazione:
+62.99%
Intervallo 1D:
$2.041
$2.15
Intervallo di 1 settimana:
$2.05
$2.38
Portata 52W:
$0.5052
$3.22
Spero Therapeutics Inc Stock (SPRO) Company Profile
Nome
Spero Therapeutics Inc
Settore
Industria
Telefono
857-242-1600
Indirizzo
675 MASSACHUSETTS AVENUE, CAMBRIDGE, MA
Confronta SPRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SPRO
Spero Therapeutics Inc
|
2.041 | 123.00M | 76.19M | -1.61M | 28.98M | 0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.27 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
559.64 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.58 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
641.42 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
297.15 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Spero Therapeutics Inc Stock (SPRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-20 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-09-23 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-10-01 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-01-22 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-16 | Iniziato | Berenberg | Buy |
| 2020-09-29 | Iniziato | Evercore ISI | Outperform |
| 2019-11-05 | Reiterato | H.C. Wainwright | Buy |
| 2019-09-09 | Iniziato | Janney | Buy |
| 2018-02-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-11-27 | Iniziato | BofA/Merrill | Neutral |
| 2017-11-27 | Iniziato | Oppenheimer | Outperform |
| 2017-11-27 | Iniziato | Stifel | Buy |
Mostra tutto
Spero Therapeutics Inc Borsa (SPRO) Ultime notizie
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2025 Earnings Call Transcript - Insider Monkey
Spero Therapeutics Inc (SPRO) Q2 2025 Earnings Call Highlights: Tepipenem HBR Trial Success and ... - Yahoo Finance
Spero Therapeutics Q2 2025 Earnings Report - MarketBeat
Spero Therapeutics 2025 Q2 Earnings Strong Performance as Net Loss Declines 90.5% - AInvest
Spero Therapeutics' Q2 2025 Earnings: A Pivotal Moment for Antibiotic Innovation and Shareholder Value - AInvest
Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update - GlobeNewswire
Earnings call transcript: Spero Therapeutics beats Q2 2025 forecasts, stock rises - Investing.com Nigeria
Earnings call transcript: Spero Therapeutics beats Q2 2025 forecasts, stock rises By Investing.com - Investing.com South Africa
Spero Therapeutics earnings beat by $0.54, revenue topped estimates - Investing.com Canada
Using Python tools to backtest Spero Therapeutics Inc. strategiesDay Trading Setup and Momentum Analysis - Newser
Spero Therapeutics SPRO 2025Q2 Earnings Preview Upside Anticipated on Drug Pipeline Expansion - AInvest
Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025 - The Globe and Mail
Spero leads infectious disease gains with 252% stock jump - BioWorld MedTech
Biotech Co. AIRNA Adds Ex-Spero Legal Chief As Its 1st CLO - Law360
Spero Therapeutics to Report Second Quarter 2025 Financial - GlobeNewswire
Spero Q2 2025 Earnings: Rare Disease and MDR Treatment Pipeline Updates Coming August 12 - Stock Titan
How does Spero Therapeutics Inc. generate profit in a changing economyGet alerts on high-potential stock breakouts - Jammu Links News
What drives Spero Therapeutics Inc. stock priceInvest confidently with proven investment plans - Jammu Links News
Is Spero Therapeutics Inc. stock overvalued or undervaluedOverwhelming profit margins - Jammu Links News
Is it the right time to buy Spero Therapeutics Inc. stockUnlock superior stock analysis tools - Jammu Links News
Should I hold or sell Spero Therapeutics Inc. stock in 2025Achieve breakthrough investment performance - Jammu Links News
What catalysts could drive Spero Therapeutics Inc. stock higher in 2025Get exclusive access to expert stock recommendations - Jammu Links News
Spero Therapeutics Inc. Stock Analysis and ForecastExceptional trading results - Jammu Links News
What are the latest earnings results for Spero Therapeutics Inc.Exceptional financial outcomes - Jammu Links News
How volatile is Spero Therapeutics Inc. stock compared to the marketTremendous growth potential - Jammu Links News
What institutional investors are buying Spero Therapeutics Inc. stockCapitalize on emerging industry trends - Jammu Links News
How many analysts rate Spero Therapeutics Inc. as a “Buy”Free Smart Trading Workshop - Jammu Links News
Spero Therapeutics Inc. Stock Support and Resistance Levels You Should KnowInvestment Roadmap for High Potential Stocks - Newser
Trend analysis for Spero Therapeutics Inc. this weekSmart Chart Forecasting with AI Algorithms - Newser
How hedge fund analytics apply to Spero Therapeutics Inc. stockPattern Breakout Prediction for Short Term - Newser
Spero Therapeutics Inc. Breaks Losing Streak — Is the Trend ReversingProfit Target Stock Opportunity Monitor Activated - metal.it
Spero Therapeutics Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
What momentum shifts mean for Spero Therapeutics Inc.Predictable Income Summary for Long-Term Trades - Newser
Spero Therapeutics SPRO 2025Q2 Earnings Preview Upside Ahead on Strong Revenue Growth Prospects - AInvest
What is the risk reward ratio of investing in Spero Therapeutics Inc. stockPre Market Trend Scanner With High Returns - jammulinksnews.com
How Spero Therapeutics Inc. stock performs during market volatilitySmart Trade Forecast Based on Neural Logic - Newser
Spero Therapeutics Inc. Matches Institutional Buying FilterAccurate Buy Point for Momentum Stocks Detected - metal.it
What makes Spero Therapeutics Inc. stock price move sharplyFree Real Time Stock Movement Analysis - Newser
Multi factor analysis applied to Spero Therapeutics Inc.Free Weekly Setup With 3x Return Potential - Newser
Can Spero Therapeutics Inc. Regain Momentum After BreakdownWeekly Top Gainers Forecast Watchlist Released - beatles.ru
Will Spero Therapeutics Inc. stock benefit from AI tech trendsAI Triggered Buy Zone Forecast System - Newser
Why is Spero Therapeutics Inc. stock attracting strong analyst attentionSwing Trade Review With Proven Results - Jammu Links News
When is Spero Therapeutics Inc. stock expected to show significant growthOutstanding investment returns - Jammu Links News
Spero Therapeutics Inc Azioni (SPRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
5.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):